Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY (2008) Nature 452: 713-8 ATR: an essential regulator of genome integrity. Cimprich KA, Cortez D (2008) Nat Rev Mol Cell Biol 9: 616-27 Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Bowman AB, Lam YC, Jafar-Nejad P, Chen HK, Richman R, Samaco RC, Fryer JD, Kahle JJ, Orr HT, Zoghbi HY (2007) Nat Genet 39: 373-9 A role for proapoptotic BID in the DNA-damage response. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ (2005) Cell 122: 579-91 Bid plays a role in the DNA damage response. Zinkel SS, Hurov KE, Gross A (2007) Cell 130: 9-10; author reply 10-1 ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, Fryer JD, Hyun ED, Duvick LA, Orr HT, Botas J, Zoghbi HY (2006) Cell 127: 1335-47 Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Cortez D, Wang Y, Qin J, Elledge SJ (1999) Science 286: 1162-6 ATR and ATRIP: partners in checkpoint signaling. Cortez D, Guntuku S, Qin J, Elledge SJ (2001) Science 294: 1713-6 Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Lancet Oncol 12: 477-88 The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM (2003) Cancer Cell 3: 185-97 ETAA1 acts at stalled replication forks to maintain genome integrity. Bass TE, Luzwick JW, Kavanaugh G, Carroll C, Dungrawala H, Glick GG, Feldkamp MD, Putney R, Chazin WJ, Cortez D (2016) Nat Cell Biol 18: 1185-1195 The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability. Dungrawala H, Rose KL, Bhat KP, Mohni KN, Glick GG, Couch FB, Cortez D (2015) Mol Cell 59: 998-1010 Checkpoint signaling from a single DNA interstrand crosslink. Ben-Yehoyada M, Wang LC, Kozekov ID, Rizzo CJ, Gottesman ME, Gautier J (2009) Mol Cell 35: 704-15 Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response. Desimone MC, Rathmell WK, Threadgill DW (2013) J Natl Cancer Inst 105: 1355-64 Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Zou L, Cortez D, Elledge SJ (2002) Genes Dev 16: 198-208 Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ (2000) Genes Dev 14: 1448-59 ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Couch FB, Bansbach CE, Driscoll R, Luzwick JW, Glick GG, Bétous R, Carroll CM, Jung SY, Qin J, Cimprich KA, Cortez D (2013) Genes Dev 27: 1610-23 Unwind and slow down: checkpoint activation by helicase and polymerase uncoupling. Cortez D (2005) Genes Dev 19: 1007-12 Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT (2000) Genes Dev 14: 2989-3002 Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Cortez D, Glick G, Elledge SJ (2004) Proc Natl Acad Sci U S A 101: 10078-83 Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ, Wynshaw-Boris A, Levine RL (1999) Proc Natl Acad Sci U S A 96: 9915-9 Functional genomic screens identify CINP as a genome maintenance protein. Lovejoy CA, Xu X, Bansbach CE, Glick GG, Zhao R, Ye F, Sirbu BM, Titus LC, Shyr Y, Cortez D (2009) Proc Natl Acad Sci U S A 106: 19304-9 DNA damage response: three levels of DNA repair regulation. Sirbu BM, Cortez D (2013) Cold Spring Harb Perspect Biol 5: a012724 Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D (2007) Cancer Res 67: 6685-90 ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency. Mohni KN, Kavanaugh GM, Cortez D (2014) Cancer Res 74: 2835-45 Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress. Liu Y, Bertram CC, Shi Q, Zinkel SS (2011) Cell Death Differ 18: 841-52 The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm-/- mice. Biswas S, Shi Q, Wernick A, Aiello A, Zinkel SS (2013) Cell Death Differ 20: 869-77 Bid protects the mouse hematopoietic system following hydroxyurea-induced replicative stress. Liu Y, Aiello A, Zinkel SS (2012) Cell Death Differ 19: 1602-12 Clinical Reasoning: A 57-year-old woman with ataxia and oscillopsia: Varicella-zoster encephalitis. Bradshaw MJ, Gilden D, Lavin P, Sriram S (2016) Neurology 87: e61-4 Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N (2012) Clin Cancer Res 18: 1257-67 Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy. Liu G, Berlin J, Tutsch KD, Van Ummersen L, Dresen A, Marnocha R, Arzomanian R, Alberti D, Feierabend C, Binger K, Wilding G (2002) Clin Cancer Res 8: 706-11 Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A (2013) EMBO Mol Med 5: 149-66 A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD, Aschner M, Bowman AB (2015) Hum Mol Genet 24: 1929-44 Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY (2005) Hum Mol Genet 14: 679-91 Genetic modifiers of neurological disease. Kearney JA (2011) Curr Opin Genet Dev 21: 349-53 Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Stewart ZA, Tang LJ, Pietenpol JA (2001) Oncogene 20: 113-24 Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway. McConnell JL, Gomez RJ, McCorvey LR, Law BK, Wadzinski BE (2007) Oncogene 26: 6021-30
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.